Business Description
Parmax Pharma Ltd
ISIN : INE240T01014
Total Employee Number:
82Compare
Compare
Traded in other countries / regions
540359.India IPO Date
2017-03-16Description
Parmax Pharma Ltd is a pharmaceutical company. The company manufactures and sells Tablets, Capsules, Ointments, and injectables. Its Core Segments: Anti-infectives, Analgesics & anti-inflammatory, Cardiovascular APIs, General oral formulations (tablets, capsules) Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Paliperidone, Lacosamide, 2-Acetyl Benzo(B) Thiophene, Camphor Sulfonyl Chloride, 3-Methoxy Thiophene, Silodosin API, and others.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -0.22 | |||||
Debt-to-Equity | -1.87 | |||||
Debt-to-EBITDA | -3.25 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 0.3 | |||||
Beneish M-Score | 0.24 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.9 | |||||
3-Year FCF Growth Rate | -75 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.92 | |||||
9-Day RSI | 98.65 | |||||
14-Day RSI | 96.02 | |||||
3-1 Month Momentum % | 104.66 | |||||
6-1 Month Momentum % | 108.72 | |||||
12-1 Month Momentum % | 69.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.74 | |||||
Quick Ratio | 0.39 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 175.46 | |||||
Days Sales Outstanding | 44.99 | |||||
Days Payable | 411.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -12.17 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.42 | |||||
Operating Margin % | -37.99 | |||||
Net Margin % | -34.34 | |||||
EBITDA Margin % | -29.23 | |||||
FCF Margin % | -26.88 | |||||
OCF Margin % | -19.45 | |||||
ROA % | -19.36 | |||||
ROIC % | -23.32 | |||||
ROC (Joel Greenblatt) % | -57.49 | |||||
ROCE % | -76.91 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.18 | |||||
EV-to-EBIT | -10.85 | |||||
EV-to-EBITDA | -13.94 | |||||
EV-to-Revenue | 4.07 | |||||
EV-to-FCF | -14.94 | |||||
Price-to-GF-Value | 4.03 | |||||
Earnings Yield (Greenblatt) % | -9.22 | |||||
FCF Yield % | -8.45 | |||||
Forward Rate of Return (Yacktman) % | 18.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Parmax Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 121.116 | ||
| EPS (TTM) (₹) | -11.12 | ||
| Beta | 0.9972 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 2.11 | ||
| Volatility % | 117.21 | ||
| 14-Day RSI | 96.02 | ||
| 14-Day ATR (₹) | 2.063961 | ||
| 20-Day SMA (₹) | 85.9105 | ||
| 12-1 Month Momentum % | 69.8 | ||
| 52-Week Range (₹) | 22.6 - 102.92 | ||
| Shares Outstanding (Mil) | 3.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Parmax Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Parmax Pharma Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Parmax Pharma Ltd Frequently Asked Questions
What is Parmax Pharma Ltd(BOM:540359)'s stock price today?
The current price of BOM:540359 is ₹102.92. The 52 week high of BOM:540359 is ₹102.92 and 52 week low is ₹22.60.
When is next earnings date of Parmax Pharma Ltd(BOM:540359)?
The next earnings date of Parmax Pharma Ltd(BOM:540359) is .
Does Parmax Pharma Ltd(BOM:540359) pay dividends? If so, how much?
Parmax Pharma Ltd(BOM:540359) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Parmax Pharma Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers